Prevalence of breast cancer in thyroid diseases: Results of a cross-sectional study of 3,921 patients

Breast Cancer Research and Treatment

Volumn 144, Issue 3, 2014, Pages 683-688

  Prinzi, Natalie ^a   Baldini, Enke ^a   Sorrenti, Salvatore ^a   De Vito, Corrado ^b   Tuccilli, Chiara ^a   Catania, Antonio ^a   Carbotta, Sabino ^a   Mocini, Renzo ^a   Coccaro, Carmela ^a   Nesca, Angela ^a   Bianchini, Marta ^a   De Antoni, Enrico ^a   D'Armiento, Massimino ^a   Ulisse, Salvatore ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anti thyroglobulin antibody; Anti thyroperoxidase antibody; Anti TSH receptor antibody; Breast cancer; Oestrogen; Oestrogen receptor; Thyroid disease; Thyroid hormone; Thyroid hormone receptor; TSH

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTOIMMUNE HYPOTHYROIDISM; BREAST CANCER; CANCER RISK; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GRAVES DISEASE; HIGH RISK POPULATION; HUMAN; HYPOTHYROIDISM; ITALY; LYMPHOCYTIC THYROIDITIS; MAJOR CLINICAL STUDY; NODULAR THYROID DISEASE; NON NODULAR THYROID DISEASE; POPULATION; PREVALENCE; PRIORITY JOURNAL; THYROID CANCER; THYROID DISEASE; THYROTROPIN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOIMMUNITY; BREAST NEOPLASMS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; REGISTRIES; THYROID DISEASES; YOUNG ADULT;

EID: 84899477256     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2893-y     Document Type: Article

References (46)

1. Vanderpump MPJ (2011) The epidemiology of thyroid disease. Br Med Bull 99:39-51
2. Gharib M, Gharib H (2011) Guidelines for the diagnosis and management of thyroid nodules. Thyroid Int 1:3-11
3. Mehanna HM, Jain A, Morton RP, Watkinson J, Shaha A (2009) Investigating the thyroid nodule. BMJ 338:b733
4. Trimboli P, Ulisse S, Graziano FM, Marzullo A, Ruggieri M, Calvanese A, Piccirilli F, Cavaliere R, Fumarola A, D'Armiento M (2006) Trend in thyroid carcinoma size, age at diagnosis and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid 16:1151-1155 (Pubitemid 44864490)
5. Paschke R (2011) Molecular pathogenesis of nodular goiter. Langenbecks Arch Surg 396:1127-1136
6. Nikiforov YE, Biddinger PW, Thompson LDR (2009) Diagnostic pathology and molecular genetics of the thyroid. Wolters Kluwer-Lippincott Williams & Wilkins, Philadelphia
7. Bonora E, Tallini G, Romeo G (2010) Genetic predisposition to familial nonmedullary thyroid cancer: an update of molecular findings and state-of-art studies. J Oncol. doi:10.1155/2010/385206
8. Lal G, Groff M, Howe JR, Weigel RJ, Sugg SL, Lynch CF (2012) Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study. Ann Surg Oncol 19:1887-1896
9. Taylor AJ, Croft AP, Palace AM, Winter DL, Reulen RC, Stiller CA, Stevens MC, Hawkins MM (2009) Risk of thyroid cancer in survivors of childhood cancer: results from the british childhood cancer survivor study. Int J Cancer 125:2400-2405
10. Bhatti P, Veiga LH, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, Weathers R, Leisenring W, Mertens AC, Hammond S, Friedman DL, Neglia JP, Meadows AT, Donaldson SS, Sklar CA, Robison LL, Inskip PD (2010) Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study. Radiat Res 174:741-752
11. Armstrong GT, Stovall M, Robison LL (2010) Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res 174:840-850
12. Canchola AJ, Horn-Ross PL, Purdie DM (2006) Risk of second primary malignancies in women with papillary thyroid cancer. Am J Epidemiol 163:521-527
13. Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, Straus S, Ezzat S, Goldstein DP (2009) Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid 19:451-457
14. Brown AP, Chen J, Hitchcock YI, Szabo A, Shrieve DC, Tward JD (2008) The risk of second primary malignancy up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab 93:504-515 (Pubitemid 351240823)
15. Berthe E, Henty-Amar M, Michels J-J, Rame JP, Berthet P, Babin E, Icard P, Samama G, Galateau-Sallé F, Mahoudeau J, Bardet S (2004) Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imag 31:685-691 (Pubitemid 38647907)
16. Rubino C, de Vathaire F, Dottorini ME, Hall P, Schvartz C, Couette JE, Dondon MG, Abbas MT, Langlois C, Schlumberger M (2003) Second primary malignancies in thyroid cancer patients. Br J Cancer 89:1638-1644 (Pubitemid 37464133)
17. Subramanian S, Goldstein DP, Parlea L, Thabane L, Ezzat S, Ibrahim-Zada I, Straus S, Brierley JD, Tsang RW, Gafni A, Rotstein L, Sawka AM (2007) Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid 17:1277-1288
18. Ronckers CM, McCarron P, Ron E (2005) Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer 117:281-288 (Pubitemid 41377449)
19. Chuang SC, Hashibe M, Yu GP, Le AD, Cao W, Hurwitz EL, Rao JY, Neugut AI, Zhang ZF (2006) Radiotherapy for primary thyroid cancer as a risk factor for second primary cancers. Cancer Lett 238:42-52 (Pubitemid 43851143)
20. Sandeep TC, Strachan MWJ, Reynolds RM, Brewster DH, Scélo G, Pukkala E, Hemminki K, Anderson A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kirn V, Kliewer EV, Tonita JM, Jonasson JG, Martos C, Boffetta P, Brennan P (2006) Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol Metab 91:1819-1825
21. Hardefeldt PJ, Eslick GD, Edirimanne S (2012) Benign thyroid disease is associated with breast cancer: a meta-analysis. Breast Cancer Res Treat 133:1169-1177
22. Sarlis NJ, Gourgiotis L, Pucino F, Tollis GJ (2002) Lack of association between Hashimoto thyroiditis and breast cancer: a quantitative research synthesis. Hormones 1:35-41
23. Tosovic A, Becker C, Bondeson AG, Bondeson L, Ericsson UB, Malm J, Manjer J (2012) Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. Int J Cancer 131:2126-2133
24. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA, American Association Of Clinical Endocrinologists And American Thyroid Association Taskforce On Hypothyroidism In Adults (2012) Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 22:1200-1235
25. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN, American Thyroid Association; American Association of Clinical Endocrinologists (2011) Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract 17:456-520
26. Sherman SI (2003) Thyroid carcinoma. Lancet 361:501-511
27. Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA, American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults (2012) Clinical practice guidelines for hypothyroidism in adults: co-sponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 18:988-1028
28. Trimboli P, Ulisse S, D'Alò M, Solari F, Fumarola A, Ruggieri M, De Antoni E, Catania A, Sorrenti S, Nardi F, D'Armiento M (2008) Analysis of clinical, ultrasound and colour flow-Doppler characteristics in predicting malignancy in follicular thyroid neoplasms. Clin Endocrinol 69:342-344 (Pubitemid 352009010)
29. Aghini-Lombardi F, Antonangeli L, Vitti P, Pinchera A (1993) Status of iodine nutrition in Italy. In: Dunn JT, Glinoer D (eds) Delange F. Plenum Press, New York, Iodine Deficiency in Europe. A Continuing Concern., pp 403-408
30. AIRTUM Working Group (2010) Italian cancer figures, report 2010: cancer prevalence in Italy. Patients living with cancer, long term survivors and cured patients. Epidemiol Prev 34:1-188
31. Smyth PP, Shering SG, Kilbane MT, Murray MJ, McDermott EW, Smith DF, O'Higgins NJ (1998) Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma. J Clin Endocrinol Metab 83:2711-2716 (Pubitemid 28493765)
32. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K (2010) Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden. Br J Cancer 102:1397-1399
33. Cerbon MA, Pichon MF, Milgrom E (1981) Thyroid hormone receptors in human breast cancer. Cancer Res 41:4167-4173 (Pubitemid 11011214)
34. Silva JM, Domínguez G, González-Sancho JM, García JM, Silva J, García-Andrade C, Navarro A, Muñoz A, Bonilla F (2002) Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer. Oncogene 21:4307-4316 (Pubitemid 34753837)
35. Nogueira CR, Brentani MM (1996) Triiodothyronine mimics the effects of estrogen in breast cancer cell lines. J Steroid Biochem Mol Biol 59:271-279 (Pubitemid 27037933)
36. Ulisse S, Tata JR (1994) Thyroid hormone and glucocorticoid independently regulate the expression of estrogen receptor in male Xenopus liver cells. Mol Cell Endocrinol 105:45-53 (Pubitemid 24289684)
37. Alarid ET, Preisler-Mashek MT, Solodin NM (2003) Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary. Endocrinology 144:3469-3476 (Pubitemid 36904424)
38. Cengiz O, Bozkurt B, Unal B, Yildirim O, Karabeyoglu M, Eroglu A, Koçer B, Ulaş M (2004) The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. J Surg Oncol 87:19-25 (Pubitemid 38880275)
39. Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, Hsu L, Krishnamurthy S, Theriault RL, Hortobagyi GN (2005) Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103:1122-1128 (Pubitemid 40328081)
40. Ditsch N, Liebhardt S, Von Koch F, Lenhard M, Vogeser M, Spitzweg C, Gallwas J, Toth B (2010) Thyroid function in breast cancer patients. Anticancer Res 30:1713-1718
41. Cecconi S, Rucci N, Scaldaferri ML, Masciulli MP, Rossi G, Moretti C, D'Armiento M, Ulisse S (1999) Thyroid hormone effects on mouse oocyte maturation and granulosa cell aromatase activity. Endocrinology 140:1783-1788 (Pubitemid 29149250)
42. Ulisse S, Jannini EA, Carosa E, Piersanti D, Graziano FM, D'Armiento M (1994) Inhibition of aromatase activity in rat Sertoli cells by thyroid hormone. J Endocrinol 140:431-436 (Pubitemid 24117210)
43. Kuijpens JL, Nyklíctek I, Louwman MW, Weetman TA, Pop VJ, Coebergh JW (2005) Hypothyroidism might be related to breast cancer in post-menopausal women. Thyroid 15:1253-1259 (Pubitemid 41821759)
44. Sandhu MK, Brezden-Masley C, Lipscombe LL, Zagorski B, Booth GL (2009) Autoimmune hypothyroidism and breast cancer in the elderly. Breast Cancer Res Treat 115:635-641
45. Smyth PP (2003) Role of iodine in antioxidant defence in thyroid and breast disease. BioFactors 19:121-130
46. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Zhao QH, Deng HF, Amenta PS, Fineberg S, Pestell RG, Carrasco N (2000) The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871-878 (Pubitemid 30644744)